Sepsis, a life-threatening disease caused by infection, presents a major global health challenge due to its high morbidity and mortality rates. A rapid and precise diagnosis of sepsis is essential for better patient outcomes….
Continue Reading
A mounting cybersecurity crisis is threatening America’s healthcare infrastructure as small and rural hospitals increasingly delay critical security improvements. According to a comprehensive June 30 report from Black Book Research, financial pressures from looming…
Continue Reading
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Josh Canavan, Head of Pharmacy at RazorMetrics
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients…
Continue Reading
Delays in translating new medical evidence into clinical practice hinder patient access to the best available treatments. Our data reveals an average delay of nine years from the initiation of human research to its…
Continue Reading
Accurate assessment of progression and disease course in multiple sclerosis (MS) is vital for timely and appropriate clinical intervention. The gradual transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is often diagnosed…
Continue Reading
Gerardo Dada, Field Chief Technology Officer (CTO) at Catchpoint
If we learned anything from the CrowdStrike fiasco of July 2024, it’s how much our daily lives depend on digital systems and how that reliance can…
Continue Reading
What You Should Know:
– Sohar Health, an AI-driven provider of eligibility determination and Verification of Benefits (VoB) raises $3.8M in seed funding round led by Kindred Capital, with participation from Y Combinator, General Catalyst,…
Continue Reading
The U.S. Drug Enforcement Administration and the Department of Health and Human Services will delay the effective date of two final rules that were expected to go into effect on Friday, March 21. By extending…
Continue Reading
Study Reveals Alarming Reporting Delays
A groundbreaking study published in The BMJ has uncovered a disturbing trend in the medical device industry: nearly one-third of adverse event reports are submitted late to the FDA. More…
